These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


722 related items for PubMed ID: 16644744

  • 1. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ.
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [Abstract] [Full Text] [Related]

  • 5. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K.
    Rofo; 2002 Jun 01; 174(6):714-20. PubMed ID: 12063600
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT for staging of penile cancer.
    Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.
    J Nucl Med; 2005 Sep 01; 46(9):1460-5. PubMed ID: 16157528
    [Abstract] [Full Text] [Related]

  • 7. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
    Kim MR, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Eur J Surg Oncol; 2007 Jun 01; 33(5):633-8. PubMed ID: 17391904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
    Yang W, Fu Z, Yu J, Yuan S, Zhang B, Li D, Xing L, Zhao D, Mu D, Sun X, Fang Y, Huang Y, Li W.
    Lung Cancer; 2008 Jul 01; 61(1):35-43. PubMed ID: 18177978
    [Abstract] [Full Text] [Related]

  • 11. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.
    J Nucl Med; 2009 Aug 01; 50(8):1205-13. PubMed ID: 19617339
    [Abstract] [Full Text] [Related]

  • 12. High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
    Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C.
    Nucl Med Commun; 2010 Jun 01; 31(6):506-12. PubMed ID: 20168262
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
    Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Cho KJ, Lee SW, Kim SB, Roh JL.
    Ann Surg Oncol; 2011 Sep 01; 18(9):2579-84. PubMed ID: 21409485
    [Abstract] [Full Text] [Related]

  • 14. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.
    Arch Otolaryngol Head Neck Surg; 2007 May 01; 133(5):435-40. PubMed ID: 17515501
    [Abstract] [Full Text] [Related]

  • 15. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.
    J Nucl Med; 2009 Apr 01; 50(4):506-12. PubMed ID: 19289438
    [Abstract] [Full Text] [Related]

  • 16. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.
    Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, Inose T, Faried A, Saito K, Ieta K, Sohda M, Fukai Y, Miyazaki T, Masuda N, Fukuchi M, Ojima H, Tsukada K, Oriuchi N, Endo K, Kuwano H.
    Oncol Rep; 2008 Oct 01; 20(4):857-62. PubMed ID: 18813827
    [Abstract] [Full Text] [Related]

  • 17. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.
    Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA.
    Ann Thorac Surg; 2004 Sep 01; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041
    [Abstract] [Full Text] [Related]

  • 18. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W, Jian W, Li HT, Li C, Zhang YK, Xie B, Zhou DQ, Dai YM, Lin Y, Lu M, Huang XQ, Xu CX, Chen L.
    Magn Reson Imaging; 2010 Jun 01; 28(5):613-20. PubMed ID: 20418042
    [Abstract] [Full Text] [Related]

  • 19. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C, Carlson ER, Duncan LD, Blodgett TM, Kennedy J, Long MJ, Carr C, Hubner KF, Townsend DW.
    J Oral Maxillofac Surg; 2007 Dec 01; 65(12):2524-35. PubMed ID: 18022480
    [Abstract] [Full Text] [Related]

  • 20. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.
    Nucl Med Commun; 2010 Jun 01; 31(6):576-82. PubMed ID: 20216474
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.